Search For "active pharmaceutical ingredient"
Rising input costs to hurt profitability of Indian pharma sector in 2022-2
Updated : 3 years, 10 months ago IST
New Delhi [India], July 19 (ANI): Faced with rising prices of active pharmaceutical ingredients (APIs), and other key inputs coupled with a rise in freight and energy costs, the operating profitability of Indian pharmaceutical companies is expected to decline by 200-250 basis points (or 2.5
Read More
Income Tax Dept conducts searches on Bengaluru-based pharmaceutical firm
Updated : 3 years, 10 months ago IST
New Delhi [India], July 13 (ANI): The Income Tax Department said on Wednesday it has conducted search and seizure operations against a Bengaluru-based pharmaceutical firm for alleged irregularities and tax evasion.
Read More
Bajaj Healthcare forays into opiate processing, receives two tenders from
Updated : 3 years, 10 months ago IST
New Delhi [India], July 13 (ANI): Bajaj Healthcare has forayed into highly-regulated opiate processing as it received two tenders from the central government for manufacturing of concentrated poppy straw and alkaloids/active pharmaceutical ingredients (APIs) from unlanced poppy capsules alon
Read More
Rupus Global Limited to make inroads in Africa & UAE to launch about 5
Updated : 4 years ago IST
California [US], May 10 (ANI/NewsVoir): Headquartered at Hong Kong, Rupus Global Limited (rupusglobal.com), one of the fastest growing pharmaceutical company with leadership position in active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and provides contract research and
Read More
Dr Ajit Kamath, MD of Arch Pharmalabs honoured with Professorship at Unive
Updated : 4 years ago IST
New Delhi [India], May 9 (ANI/PNN): Dr Ajit Kamath, Founder & Managing Director of Arch Pharmalabs Limited, a Mumbai based globally acclaimed research-focused vertically integrated pharmaceutical company, which contract manufactures Active Pharmaceutical Ingredients (APIs), and provides
Read More
Academic research scholar Dr Kannan Vishwanatth was conferred Honorary Pro
Updated : 4 years, 1 month ago IST
California [US], April 16 (Newsvoir/ANI): (Prof) Dr Kannan Vishwanatth, noted academic researcher & Founder & Managing Director of Hong Kong based Rupus Global Limited, a globally acclaimed research-focused vertically integrated pharmaceutical Company, which contract manufactures act
Read More
Local manufacturing of 35 APIs in 32 plants starts under PLI scheme: Mansu
Updated : 4 years, 2 months ago IST
New Delhi [India], March 29 (ANI): The manufacturing of 35 active pharmaceutical ingredients (APIs), which have been imported earlier, started in India under the production linked scheme, said Union Health Minister Mansukh Mandaviya on Tuesday.
Read More
Supriya Lifescience makes stock market debut at 55 per cent premium
Updated : 4 years, 5 months ago IST
Mumbai [India], December 28 (ANI): Supriya Lifescience, an active pharmaceutical ingredients manufacturer, made a strong debut at the stock market on Tuesday with its share getting listed at 55 per cent premium over its issue price of Rs.274 per share.
Read More
Evexia Lifecare Ltd plans major expansion; to enter into Bullion Trading
Updated : 4 years, 7 months ago IST
Vadodara (Gujarat) [India], October 11 (ANI/PNN): BSE listed (524444), Evexia Lifecare Limited has received initial plant layout permission from FDA to set up Active Pharmaceutical Ingredient (API) manufacturing plant of Isometamidium (Isometa) in addition to the current ongoing commercial a
Read More
Fitch affirms Glenmark Pharmaceuticals at BB on IPO of API business
Updated : 4 years, 9 months ago IST
Singapore, August 10 (ANI): Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB after its active pharmaceutical ingredient (API) business completed an initial public offering (IPO).
Read More
Jubilant Pharma ratings unaffected by proposed reorganisation: Fitch
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], July 30 (ANI): The proposed transfer of Jubilant Pharma Ltd's (JPL's) active pharmaceutical ingredients (API) business to its parent Jubilant Pharmova Ltd (JPHL) will not affect JPL's ratings, says Fitch Ratings.
Read More
Morepen seals Rs 750 crore investment from Corinth Group of Switzerland
Updated : 5 years, 1 month ago IST
New Delhi [India], April 28 (ANI): The board of directors at Morepen Laboratories Ltd on Wednesday approved the investment proposed by Corinth Group, a global private investment firm headquartered in Switzerland, to the extent of 100 million dollars (about Rs 750 crore).
Read More